Moving from opacity to transparency in pharmaceutical policy

CMAJ. Canadian Medical Association Journal

Volumn 178, Issue 4, 2008, Pages 428-431

  Dhalla, Irfan ^a   Laupacis, Andreas ^a,b,c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DECISION MAKING; DRUG FORMULARY; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MARKETING; DRUG SCREENING; FOOD AND DRUG ADMINISTRATION; HUMAN; NOTE; POSTMARKETING SURVEILLANCE; PRACTICE GUIDELINE; PROSPECTIVE PRICING; REIMBURSEMENT;

EID: 39749119348     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.070799     Document Type: Note

References (24)